Effect of Hepatic Impairment on the Pharmacokinetics of Single-Dose Viloxazine Extended-Release Capsules (Qelbree®) in Adults
Study Overview The investigation focused on how hepatic impairment affects the pharmacokinetics of viloxazine extended-release capsules, branded as Qelbree®, in […]
